| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |